THE COMBINATION OF VENETOCLAX AND IBRUTINIB IS EFFECTIVE IN RELAPSED/REFRACTORY T‐PROLYMPHOCYTIC LEUKEMIA AND INFLUENCES BCL‐2‐FAMILY MEMBER DEPENDENCIES. (12th June 2019) - Kornauth, C.F.; Herbaux, C.; Boidol, B.; Guillemette, C.; Mayerhöfer, M.E.; Jäger, U.; Kubicek, S.; Davids, M.S.; Staber, P.B.